Notable Stock to Watch: China Automotive Systems (NASDAQ: CAAS) appoints Dr. Henry Lu and Dr. Tong Kooi Teo as board of directors

China Automotive Systems (NASDAQ: CAAS) spotted trading -55.60% off 52-week high price. On the other end, the stock has been noted 11.00% away from the low price over the last 52-weeks. The stock changed -0.45% to recent value of $2.22. The stock transacted 11898 shares during most recent day however it has an average volume of 11.95K shares. The company has 29.56M of outstanding shares and 12.2M shares were floated in the market.

On July 23, 2019, China Automotive Systems (NASDAQ: CAAS), a leading power steering components and systems supplier in China, reported that at the Annual General Meeting held on July 18 in Wuhan, China, Dr. Henry Lu and Dr. Tong Kooi Teo were elected as new independent members of the board of directors.

Dr. Henry Lu is the Managing Director of NBS Group. Prior to that, Dr. Lu was the Managing Director of China Merchants Capital where he led a team in healthcare and industrial sector investments. From 2012 to 2014, Dr. Lu was a Managing Partner of Sycamore Venture (China). From 2006 to 2011 he was the Chief Representative of Chicago-headquartered investment banking and asset management firm, William Blair & Company in China. Prior to that, Dr. Lu spent many years with McKinsey & Company where he advised global and regional companies such as Mercedes Benz, Honda and Johnson Controls on their growth and financial strategies. He is currently an independent director of Hong Kong-listed Hua Lien International (Holding) Company Limited and was formerly an independent director of New York Stock Exchange-listed Nepstar Drugstore Chain. Dr. Lu received a PhD from Columbia University in 1997 and a Master of Business Administration from University of Chicago Booth School of Business in 2000.

Dr. Tong Kooi Teo brings over 30 years of business experience including banking, manufacturing and investments.  He is currently the Chief Executive Officer of DPS Corporate Advisory Company Limited.  He is also a Non-Executive Director of Guocoland (China) Limited since February 2018.  Dr. Teo was a senior manager of Hong Kong-listed Guoco Group, the Managing Director of Guoco Investment (China) Ltd. from 2014 to 2018, and the Group Managing Director of Guocoland (China) Ltd. from 2012 to 2014.  Prior to that, Dr. Teo was the Chief Executive Officer of China and Vietnam Operations for Malaysia listed WCT Holdings Bhd from 2011 to 2012. Before joining WCT Holdings, Dr. Teo was the Chief Executive Officer of Singapore-listed Hong Leong Asia Ltd. from 2004 to 2010. In his early career, Dr. Teo has also held senior management positions with Tasek Corporation Bhd, Malaysia, Hong Leong Bank Malaysia and Deutsche Bank Malaysia. Dr. Teo received his Bachelor of Science and Master of Business Administration from Golden Gate University (San Francisco), and a Doctor of Professional Studies in Management Studies degree from Fordham University.

Mr. Arthur Wong and Mr. Robert Tung did not stand for re-election at the Annual General Meeting. There were no disagreements between Messrs. Wong or Tung with the Company on any matter relating to the Company´s operations, policies or practices.

Mr. Hanlin Chen, Chairman, commented, We welcome Dr. Lu and Dr. Teo to the board of directors, and we look forward to their extensive experience and business acumen to help guide our company to meet our long-term strategic goals and enhance shareholder value. At the same time, we thank Messrs. Wong and Tung for their contributions in the past years and wish them well in their future endeavors.

Its earnings per share (EPS) expected to touch remained -87.30% for this year while earning per share for the next 5-years is expected to reach at 10.00%. CAAS has a gross margin of 12.30% and an operating margin of -1.40% while its profit margin remained -0.10% for the last 12 months.

According to the most recent quarter its current ratio was 1.5 that represents company’s ability to meet its current financial obligations. The price moved ahead of -3.85% from the mean of 20 days, -3.43% from mean of 50 days SMA and performed -19.07% from mean of 200 days price. Company’s performance for the week was 3.74%, -2.20% for month and YTD performance remained -9.02%.

Leave a Reply

Your email address will not be published. Required fields are marked *